<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35204870</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9067</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>24</Day></PubDate></JournalIssue><Title>Children (Basel, Switzerland)</Title><ISOAbbreviation>Children (Basel)</ISOAbbreviation></Journal><ArticleTitle>Number of Kawasaki Disease Admissions Is Associated with Number of Domestic COVID-19 and Severe Enterovirus Case Numbers in Taiwan.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">149</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/children9020149</ELocationID><Abstract><AbstractText><b>Background:</b> Non-pharmaceutical interventions (NPIs) introduced in response to the COVID-19 pandemic, including mask-wearing and social distancing, have changed the prevalence of circulating viruses in the community. Since viral infections represent a potential triggering factor for the development of Kawasaki disease (KD), we examined the relationship between KD admission rates and the number of COVID-19, severe influenza, and severe enterovirus infections both before and after the COVID-19 pandemic. <b>Methods:</b> We conducted a retrospective study using data obtained from the Chang Gung Research Database (including seven Taiwanese hospitals and more than 10,000 beds) and the Centers for Disease Control in Taiwan from January 2018 to December 2020. We recorded the number of KD admissions, as well as COVID-19, severe influenza, and severe enterovirus infections. <b>Results:</b> The numbers of KD admissions, severe enterovirus infections, and severe influenza infections were significantly lower from April to September 2020. The number of KD hospitalizations was positively correlated with the number of domestic COVID-19 cases (<i>p</i> = 0.001). A decrease in KD admission numbers was positively correlated with a decrease in severe enterovirus case numbers (<i>p</i> = 0.007). <b>Conclusion:</b> Our findings provide further evidence that viral infections may be an important trigger factor in the development of KD. Therefore, NPIs may not only prevent transmissible viral infections in children, but also decrease the risk of KD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Mindy Ming-Huey</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0003-1829-7730</Identifier><AffiliationInfo><Affiliation>Kawasaki Disease Center, Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kuender D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, MacKay Memorial Hospital, Taipei 104217, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shih-Feng</ForeName><Initials>SF</Initials><Identifier Source="ORCID">0000-0003-1394-5401</Identifier><AffiliationInfo><Affiliation>Kawasaki Disease Center, Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Chang Gung University College of Medicine, Taoyuan 33302, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Ho-Chang</ForeName><Initials>HC</Initials><Identifier Source="ORCID">0000-0002-3295-2984</Identifier><AffiliationInfo><Affiliation>Kawasaki Disease Center, Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Chang Gung University College of Medicine, Taoyuan 33302, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Children (Basel)</MedlineTA><NlmUniqueID>101648936</NlmUniqueID><ISSNLinking>2227-9067</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Kawasaki disease</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">non-pharmaceutical interventions</Keyword></KeywordList><CoiStatement>All the authors hereby declare that they have no financial interest to disclose regarding this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>25</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35204870</ArticleId><ArticleId IdType="pmc">PMC8870605</ArticleId><ArticleId IdType="doi">10.3390/children9020149</ArticleId><ArticleId IdType="pii">children9020149</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Burgner D., Harnden A. Kawasaki disease: What is the epidemiology telling us about the etiology? Int. J. Infect. Dis. 2005;9:85–94. doi: 10.1016/j.ijid.2005.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2005.03.002</ArticleId><ArticleId IdType="pmc">PMC7110839</ArticleId><ArticleId IdType="pubmed">15936970</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G.B., Park S., Kwon B.S., Han J.W., Park Y.W., Hong Y.M. Evaluation of the Temporal Association between Kawasaki Disease and Viral Infections in South Korea. Korean Circ. J. 2014;44:250–254. doi: 10.4070/kcj.2014.44.4.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.4070/kcj.2014.44.4.250</ArticleId><ArticleId IdType="pmc">PMC4117846</ArticleId><ArticleId IdType="pubmed">25089137</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.Y., Lu C.Y., Shao P.L., Lee P.I., Lin M.T., Fan T.Y., Cheng A.L., Lee W.L., Hu J.J., Yeh S.J., et al. Viral infections associated with Kawasaki disease. J. Formos Med. Assoc. 2014;113:148–154. doi: 10.1016/j.jfma.2013.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2013.12.008</ArticleId><ArticleId IdType="pmc">PMC7125523</ArticleId><ArticleId IdType="pubmed">24495555</ArticleId></ArticleIdList></Reference><Reference><Citation>Taiwan Centers for Disease Control  Coronavirus Disease 2019 (COVID-19)  [(accessed on 27 November 2021)]; Available online:  https://www.cdc.gov.tw/en/Disease/SubIndex/</Citation></Reference><Reference><Citation>National Development Council  Population Projections for the R.O.C. (Taiwan)  [(accessed on 27 November 2021)]; Available online:  https://pop-proj.ndc.gov.tw/main_en/dataSearch.aspx?uid=78&amp;pid=78.</Citation></Reference><Reference><Citation>World Health Organization  WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 27 November 2021)].  Available online:  https://covid19.who.int/table.</Citation></Reference><Reference><Citation>Wang C.J., Ng C.Y., Brook R.H. Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing. JAMA. 2020;323:1341–1342. doi: 10.1001/jama.2020.3151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.3151</ArticleId><ArticleId IdType="pubmed">32125371</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.F., Huang Y.H., Cheng C.Y., Wu K.H., Tang K.S., Chiu I.M. Public Health Interventions for the COVID-19 Pandemic Reduce Respiratory Tract Infection-Related Visits at Pediatric Emergency Departments in Taiwan. Front. Public Health. 2020;8:604089. doi: 10.3389/fpubh.2020.604089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.604089</ArticleId><ArticleId IdType="pmc">PMC7772199</ArticleId><ArticleId IdType="pubmed">33392141</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W.C., Huang L.M., Chang I.S., Chang L.Y., Chiang B.L., Chen P.J., Wu M.H., Lue H.C., Lee C.Y. Epidemiologic features of Kawasaki disease in Taiwan, 2003–2006. Pediatrics. 2009;123:e401–e405. doi: 10.1542/peds.2008-2187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-2187</ArticleId><ArticleId IdType="pubmed">19237439</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J.M., Kim Y.E., Huh K., Hong J., Kim D.W., Kim M.Y., Jung S.Y., Kim J.H., Jung J., Ahn J.G. Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea. Circulation. 2021;143:2508–2510. doi: 10.1161/CIRCULATIONAHA.121.054785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.054785</ArticleId><ArticleId IdType="pmc">PMC8212882</ArticleId><ArticleId IdType="pubmed">34092115</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.L., Kuo H.C. Public Health Interventions for COVID-19 Reduce Kawasaki Disease in Taiwan. Children. 2021;8:623. doi: 10.3390/children8080623.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children8080623</ArticleId><ArticleId IdType="pmc">PMC8392252</ArticleId><ArticleId IdType="pubmed">34438515</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao S.C., Chan Y.Y., Kao Yang Y.H., Lin S.J., Hung M.J., Chien R.N., Lai C.C., Lai E.C. The Chang Gung Research Database—A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan. Pharmacoepidemiol. Drug Saf. 2019;28:593–600. doi: 10.1002/pds.4713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4713</ArticleId><ArticleId IdType="pubmed">30648314</ArticleId></ArticleIdList></Reference><Reference><Citation>Taiwan Centers for Disease Control  National Notifiable Disease Surveillance Report—Monthly Report.  [(accessed on 27 November 2021)]; Available online:  https://www.cdc.gov.tw/En/Report/MonthList/14567.</Citation></Reference><Reference><Citation>Katsumata N., Harama D., Toda T., Sunaga Y., Yoshizawa M., Kono Y., Hasebe Y., Koizumi K., Hoshiai M., Saito T., et al. Prevention Measures for COVID-19 and Changes in Kawasaki Disease Incidence. J. Epidemiol. 2021;31:573–580. doi: 10.2188/jea.JE20210132.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20210132</ArticleId><ArticleId IdType="pmc">PMC8502831</ArticleId><ArticleId IdType="pubmed">34483151</ArticleId></ArticleIdList></Reference><Reference><Citation>Iio K., Matsubara K., Miyakoshi C., Ota K., Yamaoka R., Eguchi J., Matsumura O., Okutani T., Ueda I., Nishiyama M. Incidence of Kawasaki disease before and during the COVID-19 pandemic: A retrospective cohort study in Japan. BMJ Paediatr. Open. 2021;5:e001034. doi: 10.1136/bmjpo-2021-001034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjpo-2021-001034</ArticleId><ArticleId IdType="pmc">PMC8023747</ArticleId><ArticleId IdType="pubmed">33884312</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara T., Furuno K., Yamamura K., Kishimoto J., Mizuno Y., Murata K., Onoyama S., Hatae K., Takemoto M., Ishizaki Y., et al. Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan. JAMA Netw. Open. 2021;4:e214475. doi: 10.1001/jamanetworkopen.2021.4475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.4475</ArticleId><ArticleId IdType="pmc">PMC8025113</ArticleId><ArticleId IdType="pubmed">33822065</ArticleId></ArticleIdList></Reference><Reference><Citation>Koskela U., Helve O., Sarvikivi E., Helminen M., Nieminen T., Peltola V., Renko M., Saxén H., Pasma H., Pokka T., et al. Multi-inflammatory syndrome and Kawasaki disease in children during the COVID-19 pandemic: A nationwide register-based study and time series analysis. Acta Paediatr. 2021;110:3063–3068. doi: 10.1111/apa.16051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.16051</ArticleId><ArticleId IdType="pmc">PMC8444808</ArticleId><ArticleId IdType="pubmed">34331326</ArticleId></ArticleIdList></Reference><Reference><Citation>Phamduy T.T., Smith S., Herbst K.W., Phamduy P.T., Brimacombe M., Hogan A.H., Salazar J.C., Sturm J. Kawasaki Disease Hospitalizations in the United States 2016–2020: A Comparison of Before and During the Coronavirus Disease 2019 Era. Pediatr. Infect Dis. J. 2021;40:e407–e412. doi: 10.1097/INF.0000000000003289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003289</ArticleId><ArticleId IdType="pmc">PMC8505141</ArticleId><ArticleId IdType="pubmed">34382611</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouldali N., Pouletty M., Mariani P., Beyler C., Blachier A., Bonacorsi S., Danis K., Chomton M., Maurice L., Le Bourgeois F., et al. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: A time-series analysis. Lancet Child Adolesc. Health. 2020;4:662–668. doi: 10.1016/S2352-4642(20)30175-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30175-9</ArticleId><ArticleId IdType="pmc">PMC7332278</ArticleId><ArticleId IdType="pubmed">32622376</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdoni L., Mazza A., Gervasoni A., Martelli L., Ruggeri M., Ciuffreda M., Bonanomi E., D’Antiga L. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020;395:1771–1778. doi: 10.1016/S0140-6736(20)31103-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31103-X</ArticleId><ArticleId IdType="pmc">PMC7220177</ArticleId><ArticleId IdType="pubmed">32410760</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzano A.V., Cassano N., Moltrasio C., Verdoni L., Genovese G., Vena G.A. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings. Dermatology. 2022;238:35–43. doi: 10.1159/000515449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000515449</ArticleId><ArticleId IdType="pmc">PMC8247806</ArticleId><ArticleId IdType="pubmed">34062530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushik A., Gupta S., Sood M., Sharma S., Verma S. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection. Pediatr. Infect Dis. J. 2020;39:e340–e346. doi: 10.1097/INF.0000000000002888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002888</ArticleId><ArticleId IdType="pubmed">32925547</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.H., Lin K.M., Ho S.C., Yan J.H., Lo M.H., Kuo H.C. Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study. Front. Pediatr. 2019;7:121. doi: 10.3389/fped.2019.00121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00121</ArticleId><ArticleId IdType="pmc">PMC6450208</ArticleId><ArticleId IdType="pubmed">30984731</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo S.H., Huang Y.C., Huang C.G., Tsao K.C., Li W.C., Hsieh Y.C., Chiu C.H., Lin T.Y. Clinical and epidemiologic features of Coxsackievirus A6 infection in children in northern Taiwan between 2004 and 2009. J. Microbiol. Immunol. Infect. 2011;44:252–257. doi: 10.1016/j.jmii.2011.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2011.01.031</ArticleId><ArticleId IdType="pubmed">21524960</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng K.P., Wei J.C., Hung Y.M., Huang S.H., Chien K.J., Lin C.C., Huang S.M., Lin C.L., Cheng M.F. Enterovirus Infection and Subsequent Risk of Kawasaki Disease: A Population-based Cohort Study. Pediatr. Infect Dis. J. 2018;37:310–315. doi: 10.1097/INF.0000000000001748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001748</ArticleId><ArticleId IdType="pubmed">28834956</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>